{"id":"W2097590048","doi":"10.1007/s00005-006-0011-5","title":"Monoclonal and bispecific antibodies as novel therapeutics","year":2006,"lang":"en","type":"review","venue":"Archivum Immunologiae et Therapiae Experimentalis","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Children's Hospital Research Institute of Manitoba; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Monoclonal antibody; Trastuzumab; Cancer research; Bispecific antibody; Antibody; Epidermal growth factor receptor; Gemtuzumab ozogamicin; Medicine; Panitumumab; Cancer; Immunoconjugate; Targeted therapy; Immunology; Pharmacology; Biology; Cetuximab; Internal medicine; Breast cancer; CD33; Stem cell; Cell biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000356802,0.001163451,0.002497964,0.0005911306,0.0003633931,0.0001814734,0.0005697118,0.0005083464,0.0004109964],"category_scores_gemma":[0.00002123592,0.0008187743,0.0009710829,0.0003517707,0.00123005,0.000142741,0.0006140228,0.001418608,0.0002469441],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001727832,"about_ca_system_score_gemma":0.0004531367,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006872024,"about_ca_topic_score_gemma":0.000008999293,"domain_scores_codex":[0.9958707,0.0003758568,0.001015046,0.001075808,0.0007002096,0.0009623741],"domain_scores_gemma":[0.9979207,0.0005836896,0.0003588309,0.0008572412,0.00007103653,0.0002084824],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000620972,0.001359501,0.0001208577,0.003941087,0.003801885,0.0002440579,0.0008983366,1.379348e-7,0.009641187,0.009542644,0.001276478,0.9685528],"study_design_scores_gemma":[0.001079713,0.001015904,0.0002615078,0.00347227,0.000409366,0.001483868,0.0002470971,0.000003976161,0.0009484993,0.0002349207,0.9900235,0.0008193825],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00237598,0.9769049,0.0000172761,0.0005810539,0.0002688252,0.001467505,0.0003734579,0.0001893232,0.01782168],"genre_scores_gemma":[0.000356399,0.9872354,0.001699888,0.0007164969,0.0002845803,0.0002658296,0.001538365,0.0002006688,0.007702426],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.988747,"threshold_uncertainty_score":0.9994263,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1197998043480238,"score_gpt":0.4345178385201128,"score_spread":0.314718034172089,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}